This HTML5 document contains 133 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
skos	http://www.w3.org/2004/02/skos/core#
rdfs	http://www.w3.org/2000/01/rdf-schema#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n12	http://dx.doi.org/10.1200/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n10	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q44459245

rdf:type

wikibase:Item

schema:description

2003年学术文章 επιστημονικό άρθρο სამეცნიერო სტატია 2003年學術文章 2003年学术文章 научни чланак bilimsel makale 2003年の論文 2003年学术文章 articolo scientifico บทความทางวิทยาศาสตร์ tieteellinen artikkeli naučni članak bài báo khoa học מאמר מדעי artículo científico publicado en 2003 article scientific teaduslik artikkel artikulong pang-agham научная статья 2003년 논문 2003年学术文章 2003年學術文章 мақолаи илмӣ 2003年学术文章 vitskapeleg artikkel vedecký článok 2003年学术文章 artigo científico مقالة علمية نشرت في يونيو 2003 artículu científicu wissenschaftlicher Artikel scientific article published in June 2003 scienca artikolo article científic научни чланак tudományos cikk artykuł naukowy vetenskaplig artikel artikull shkencor научна статия 2003年學術文章 scientific article published in June 2003 wetenschappelijk artikel scientific article published in June 2003 vědecký článek 2003年學術文章 наукова стаття, опублікована в червні 2003 vitenskapelig artikkel artigo científico articol științific artigo científico videnskabelig artikel 2003 nî lūn-bûn 2003年學術文章 জুন ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientifique artikel ilmiah

p:P577

wds:Q44459245-D2D11C18-D800-4DE6-B6AA-9F7858E40933

wdt:P577

2003-06-01T00:00:00Z

p:P407

wds:Q44459245-846DC373-C85F-4243-A197-B90494568692

wdt:P407

wd:Q1860

p:P2093

wds:Q44459245-C77690BE-18B6-4DC3-94AA-C1F49D9BA192 wds:Q44459245-C924F72A-C6E1-4956-9B1A-784A3D97750E wds:Q44459245-B9E75A21-0315-4232-8989-D4691340FF54 wds:Q44459245-BFE85D2C-7676-4965-9BA4-01C3BA99C6D5 wds:Q44459245-80A015A2-5FFC-46B0-A6DA-442EF1EC42D6 wds:Q44459245-600DF6DB-E4B6-4A71-9917-87979809E08C wds:Q44459245-77A4A7CC-C8F5-4434-8F51-96989387FC5E wds:Q44459245-60093A58-9847-4F92-BA0B-5059F48C602A wds:Q44459245-4922943C-B7DC-4F6B-8123-176E87FF4A93 wds:Q44459245-23DA39F8-CC14-4151-B994-CBF11ED1CEE9 wds:Q44459245-12DC95D0-245E-4B8C-8A5A-1ACDCE5A34A7 wds:Q44459245-1F248E28-66BC-433B-BC15-CD7B5F5116D9 wds:Q44459245-1192AFA2-8E6C-46C4-9856-3E016B1E22C0 wds:Q44459245-0BA9D617-9FF9-4935-B819-3A9E0EC3104D wds:Q44459245-05436E0E-86DB-45F8-AB89-FCDDE648F0F0 wds:Q44459245-0AA73F83-1B7F-47D9-B64F-46B9A1142D00 wds:Q44459245-FEE50FA4-41CF-4141-B144-2CE61265A2FB wds:Q44459245-D6A909DB-A9AA-4FF7-94A6-7734087EC398 wds:Q44459245-D7039881-D443-4D47-B6A1-C02F9368DAAD

wdt:P2093

Alain Monnier Robert Smith Dominique Becquart Magdolna Dank Mikhail Gershanovich Ajay Bhatnagar Ramon Perez-Carrion Eeva Salminen Poonamalle P Bapsy Fritz Jaenicke Ray Snyder Henning Mouridsen Hilary Chaudri-Ross Raquel Lang Justus Apffelstaedt Corrado Boni Harm P Sleeboom Peter Wyld Yan Sun

rdfs:label

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

skos:prefLabel

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

schema:name

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

p:P50

wds:Q44459245-30F693A9-746C-474A-B926-14382E0168AB

wdt:P50

wd:Q125317273

p:P1476

wds:Q44459245-0E669AA6-9669-4DFE-985F-BD7ABE6FEB26

wdt:P1476

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

p:P304

wds:Q44459245-8675039A-2549-49E7-B29A-E7F404B098FA

wdt:P304

2101-2109

p:P31

wds:Q44459245-E93CB786-68A7-4ECC-B69C-3EF31426D04B

wdt:P31

wd:Q13442814

p:P921

wds:Q44459245-4CCCF57E-3FC8-4A17-9351-570EDDD08777 wds:Q44459245-D2D621CE-C40B-41C5-9430-61FDB8943025 wds:Q44459245-A9FCE169-F2E0-4A66-85DC-63DE7EBE3CF0

wdt:P921

wd:Q128581 wd:Q412178 wd:Q194974

p:P698

wds:Q44459245-57B41D0F-CABB-4582-B930-4D53FB263E57

wdtn:P698

n10:12775735

wdt:P698

12775735

p:P1433

wds:Q44459245-8BADCD57-2F9A-4F4C-AD08-DA84AE709210

wdt:P1433

wd:Q400292

p:P433

wds:Q44459245-9C57CA2E-E460-4E67-8945-0C68F5E6D438

p:P478

wds:Q44459245-F6D5A808-519E-468D-A417-E50AD9B7BEC3

wdt:P433

11

wdt:P478

21

p:P356

wds:Q44459245-11A9A1DF-EC30-4842-8951-04248298061C

wdtn:P356

n12:JCO.2003.04.194

wdt:P356

10.1200/JCO.2003.04.194